GNH USA

Europe — EMA

Menopur

GNH USA supplies Menopur (Menotropin), a gonadotropin fertility agent for ovulation induction and ovarian stimulation in IVF. Request a quote for supply.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a Gonadotropin (FSH/LH) preparation presented as a lyophilized powder for injection for intramuscular, subcutaneous use. It treats anovulatory infertility and supports ovarian stimulation in assisted reproductive technologies.

GNH USA supplies Menopur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menopur is a gonadotropin preparation used in fertility treatment pathways to stimulate ovarian follicular development. - Induction of ovulation in women with anovulatory infertility: promotes follicular growth to achieve a single ovulation. - Controlled ovarian hyperstimulation for IVF: supports development of multiple follicles for egg retrieval. - Ovarian stimulation in IUI cycles: enhances follicular response to increase the chance of successful insemination.

What are the side effects of Menotrophin?

Menopur may cause a range of adverse reactions following administration.

Common Side Effects: - Injection site reactions: redness, swelling, or pain at the injection site. - Abdominal discomfort or mild pelvic pain. - Headache. - Nausea or mild gastrointestinal upset. - Mild ovarian hyperstimulation without severe complications. - Transient fatigue.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) with fluid shifts and organ dysfunction. - Multiple pregnancy (twins, triplets, etc.). - Thromboembolic events such as deep‑vein thrombosis. - Allergic reactions including anaphylaxis. - Ectopic pregnancy. - Ovarian torsion.

What precautions apply to Menotrophin?

When using Menopur, clinicians should observe several safety measures. - Monitor ovarian response: perform serial ultrasound and estradiol measurements. - Assess OHSS risk: avoid or adjust dosing in patients with polycystic ovary syndrome or prior OHSS. - Contraindicated in pregnancy: do not administer to confirmed pregnant women. - Use with caution in hormone‑sensitive cancers or uncontrolled thyroid disease. - Adjust dose in renal or hepatic impairment only under specialist guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur can interact with other hormonal or anticoagulant agents.

Major Interactions (Avoid): - GnRH agonists: may amplify ovarian response and increase OHSS risk. - hCG therapy: combined use can precipitate severe OHSS. - Estrogen‑containing contraceptives: may blunt ovarian stimulation.

Moderate Interactions (Monitor Closely): - Anticoagulants: OHSS‑related fluid shifts can raise thrombotic risk. - Thyroid hormones: altered metabolism may affect response to stimulation. - Corticosteroids: may modify follicular development and estradiol levels.

Frequently asked questions

What is Menopur used for?+
Menopur is prescribed to induce ovulation in women with anovulatory infertility and to provide controlled ovarian hyperstimulation for in‑vitro fertilisation (IVF) or other assisted reproductive technologies. It helps develop one or multiple follicles, increasing the chances of successful egg retrieval and pregnancy.
How does Menotropin work?+
Menotropin contains both follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). FSH stimulates granulosa cells to proliferate and produce estrogen, while LH supports theca‑cell androgen production that is converted to estrogen. Together they promote follicular growth, maturation, and the hormonal environment needed for ovulation.
What is the usual dose of Menopur?+
The dose of Menopur is individualized. A qualified prescriber determines the amount and frequency based on the patient’s ovarian reserve, treatment protocol, and response monitoring. Dosing may be adjusted during the stimulation cycle according to ultrasound and hormone measurements.
Is Menopur safe in pregnancy or breastfeeding?+
Menopur is not indicated for use during an established pregnancy and is contraindicated in pregnant women. Limited data exist for breastfeeding; therefore, it is generally avoided while nursing unless the benefits outweigh potential risks as assessed by a healthcare professional.
How do I order Menopur from GNH USA?+
To order Menopur, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics) and any necessary import documentation.
How does Menopur compare with the main alternative drug or class?+
Menopur (menotropin) is a urinary‑derived FSH/LH preparation, whereas many clinics use recombinant FSH (e.g., follitropin alfa) that contains only FSH activity. Menotropin provides both FSH and LH, which can be advantageous in certain protocols, but recombinant products offer higher purity and more consistent dosing.
What are the storage and handling requirements for Menopur?+
Menopur must be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking. Once reconstituted, use the solution promptly according to the manufacturer’s instructions.
How is Menopur administered?+
Menopur is supplied as a lyophilized powder for injection. After reconstitution with the appropriate diluent, it is administered by intramuscular or subcutaneous injection, typically once daily during the stimulation phase, under the supervision of a fertility specialist.
What are the most serious risks to watch for while using Menopur?+
The most serious risks include severe ovarian hyperstimulation syndrome (OHSS), which can cause fluid accumulation and organ dysfunction, multiple pregnancy, thromboembolic events, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for early signs of these complications.
Who should not use Menopur?+
Menopur is contraindicated in women who are already pregnant, have known hypersensitivity to menotropin or any excipients, have uncontrolled thyroid disease, active ovarian cysts, or a history of severe OHSS. Caution is also advised for patients with hormone‑sensitive cancers or significant cardiovascular disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring Arzneimittel Ges.M.B.H.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU